Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Sep 14, 2019; 25(34): 5185-5196
Published online Sep 14, 2019. doi: 10.3748/wjg.v25.i34.5185
Table 2 Visual analog scale scores for pain at rest and pain on movement, mean arterial pressure, and heart rate during the first 48 h after surgery
Characteristic0 h6 h12 h24 h48 h1
VAS at rest
Ropivacaine group1.94 ± 0.5391.86 ± 0.4931.77 ± 0.4581.54 ± 0.5021.49 ± 0.504
Control group1.49 ± 0.5042.15 ± 0.5572.03 ± 0.5501.63 ± 0.4871.54 ± 0.502
t-3.155-3.362-3.019-1.068-0.516
P-value0.00200.00140.00300.28760.6064
95%CI[-0.523, -0.136][-0.478, -0.126][-0.461, -0.117][-0.258, 0.074][-0.233, 0.104]
VAS on movement
Ropivacaine group2.55 ± 0.6312.74 ± 0.6102.65 ± 0.6142.42 ± 0.5791.75 ± 0.604
Control group3.27 ± 0.6873.70 ± 0.7393.51 ± 0.6603.06 ± 0.5741.97 ± 0.521
t-6.349-8.691-7.991-6.021-1.903
P-value<0.0001<0.0001<0.0001<0.00010.0271
95%CI[-0.942, -0.494][-1.192, -0.733][-1.071, -0.639][-0.835, -0.444][-0.408, -0.025]
MAP (mmHg)
Ropivacaine group90.81 ± 8.43286.00 ± 8.07086.07 ± 7.93087.61 ± 8.03786.17 ± 9.160
Control group88.78 ± 8.34890.54 ± 8.41289.15 ± 8.50489.24 ± 9.16086.28 ± 7.792
t1.414-3.210-2.183-1.104-0.075
P-value0.15960.00170.03080.27160.9402
95%CI[-0.811, 4.882][-7.333, -1.742][-5.864, -0.289][-4.550, 1.290][-2.998, 2.779]
HR (bpm)
Ropivacaine group93.36 ± 4.70691.57 ± 5.37791.58 ± 4.12092.60 ± 5.59292.63 ± 5.696
Control group94.42 ± 5.32693.25 ± 4.42793.46 ± 5.92592.81 ± 6.07992.83 ± 5.828
t-1.231-1.991-2.155-0.214-0.202
P-value0.22040.04860.03310.83080.8406
95%CI[-2.768, 0.644][-3.348, -0.011][-3.617, -0.146][-2.197, 1.768][-2.154, 1.756]
Cumulative sufentanil (µg)
Ropivacaine group013.66 ± 2.43727.91 ± 4.17655.60 ± 6.11781.66 ± 7.729
Control group015.43 ± 3.27330.93 ± 6.41461.45 ± 5.40588.89 ± 7.937
t-3.579-3.242-5.897-5.386
P-value0.00050.0016<0.0001<0.0001
95%CI[-2.744, -0.791][-4.863, -1.174][-7.803, -3.884][-9.891, -4.578]